Liu H, Wang S, Wang J, Guo X, Song Y, Fu K
Signal Transduct Target Ther. 2025; 10(1):69.
PMID: 39966374
PMC: 11836267.
DOI: 10.1038/s41392-025-02141-x.
Nan D, Yao W, Huang L, Liu R, Chen X, Xia W
Cell Commun Signal. 2025; 23(1):45.
PMID: 39856712
PMC: 11760113.
DOI: 10.1186/s12964-024-02018-6.
Grenier S, Commisso C
Trends Cancer. 2024; 11(3):196-203.
PMID: 39681506
PMC: 11903170.
DOI: 10.1016/j.trecan.2024.11.008.
Kim M, Hwang S, Jeong S
Mol Cells. 2024; 47(8):100096.
PMID: 39038517
PMC: 11342766.
DOI: 10.1016/j.mocell.2024.100096.
Yoo Y, Quan S, Yang W, Guo Q, Rodriguez Y, Chalmers Z
Cancer Res. 2024; 84(18):3004-3022.
PMID: 38959335
PMC: 11405136.
DOI: 10.1158/0008-5472.CAN-23-2910.
Mitochondria-engine with self-regulation to restore degenerated intervertebral disc cells via bioenergetic robust hydrogel design.
Wang J, Jiang Y, Zhu C, Liu Z, Qi L, Ding H
Bioact Mater. 2024; 40:1-18.
PMID: 38873262
PMC: 11167444.
DOI: 10.1016/j.bioactmat.2024.05.044.
Metabolic signature and response to glutamine deprivation are independent of p53 status in B cell malignancies.
Montironi C, Chen Z, Derks I, Cretenet G, Krap E, Eldering E
iScience. 2024; 27(5):109640.
PMID: 38680661
PMC: 11053310.
DOI: 10.1016/j.isci.2024.109640.
Exploiting the Achilles' heel of cancer: disrupting glutamine metabolism for effective cancer treatment.
Fan Y, Xue H, Li Z, Huo M, Gao H, Guan X
Front Pharmacol. 2024; 15:1345522.
PMID: 38510646
PMC: 10952006.
DOI: 10.3389/fphar.2024.1345522.
Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention.
Muranaka H, Akinsola R, Billet S, Pandol S, Hendifar A, Bhowmick N
Cancers (Basel). 2024; 16(5).
PMID: 38473414
PMC: 10930819.
DOI: 10.3390/cancers16051057.
Amino acid metabolism in tumor biology and therapy.
Chen J, Cui L, Lu S, Xu S
Cell Death Dis. 2024; 15(1):42.
PMID: 38218942
PMC: 10787762.
DOI: 10.1038/s41419-024-06435-w.
Increased SLC7A3 Expression Inhibits Tumor Cell Proliferation and Predicts a Favorable Prognosis in Breast Cancer.
He L, Xu Y, Lin J, Lin S, Lin S, Cui Y
Recent Pat Anticancer Drug Discov. 2024; 20(1):55-70.
PMID: 38204267
PMC: 11826905.
DOI: 10.2174/0115748928279007231130070056.
Glutamine addiction in tumor cell: oncogene regulation and clinical treatment.
Li X, Peng X, Li Y, Wei S, He G, Liu J
Cell Commun Signal. 2024; 22(1):12.
PMID: 38172980
PMC: 10763057.
DOI: 10.1186/s12964-023-01449-x.
Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cells.
Linder S, Bernasocchi T, Martinez-Pastor B, Sullivan K, Galbraith M, Lewis C
Nat Metab. 2023; 5(12):2131-2147.
PMID: 37957387
PMC: 11639397.
DOI: 10.1038/s42255-023-00919-3.
Research progress on the role of cationic amino acid transporter (CAT) family members in malignant tumors and immune microenvironment.
You S, Han X, Xu Y, Yao Q
Amino Acids. 2023; 55(10):1213-1222.
PMID: 37572157
DOI: 10.1007/s00726-023-03313-1.
Targeting Pulmonary Fibrosis by SLC1A5-Dependent Glutamine Transport Blockade.
Choudhury M, Schaefbauer K, Kottom T, Yi E, Tschumperlin D, Limper A
Am J Respir Cell Mol Biol. 2023; 69(4):441-455.
PMID: 37459644
PMC: 10557918.
DOI: 10.1165/rcmb.2022-0339OC.
The stress sensor GCN2 differentially controls ribosome biogenesis in colon cancer according to the nutritional context.
Piecyk M, Triki M, Laval P, Duret C, Fauvre J, Cussonneau L
Mol Oncol. 2023; 18(9):2111-2135.
PMID: 37452637
PMC: 11467793.
DOI: 10.1002/1878-0261.13491.
c-Myc protects hepatocellular carcinoma cell from ferroptosis induced by glutamine deprivation via upregulating GOT1 and Nrf2.
Zhao Y, Wang Y, Miao Z, Liu Y, Yang Q
Mol Biol Rep. 2023; 50(8):6627-6641.
PMID: 37358765
DOI: 10.1007/s11033-023-08495-1.
Identification of Basement Membrane-Related Signatures in Gastric Cancer.
Wang J, Liu D, Wang Q, Xie Y
Diagnostics (Basel). 2023; 13(11).
PMID: 37296697
PMC: 10252969.
DOI: 10.3390/diagnostics13111844.
Crosstalk between arginine, glutamine, and the branched chain amino acid metabolism in the tumor microenvironment.
Wetzel T, Erfan S, Figueroa L, Wheeler L, Ananieva E
Front Oncol. 2023; 13:1186539.
PMID: 37274280
PMC: 10235471.
DOI: 10.3389/fonc.2023.1186539.
Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol.
Gong J, Osipov A, Lorber J, Tighiouart M, Kwan A, Muranaka H
Biomedicines. 2023; 11(5).
PMID: 37239063
PMC: 10216251.
DOI: 10.3390/biomedicines11051392.